Dieter Pöhlau

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

Ludwig Kappos, Giancarlo Comi, Hillel Panitch et al. · Nature Medicine · 2000 · 514 citations

Life Sciences, Immunology, Neurology +17

MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis

Helmut Butzkueven, Joab Chapman, Edgardo Cristiano et al. · Multiple Sclerosis Journal · 2006 · 246 citations

Medicine, Biostatistics, Neurology +10

Oral fumaric acid esters for the treatment of active multiple sclerosis: an open‐label, baseline‐controlled pilot study

Sebastian Schimrigk, N. Brune, Kerstin Hellwig et al. · European Journal of Neurology · 2006 · 219 citations

Pharmacy, Neurology, Pharmacotherapy +14

Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry

Paulus Rommer, David Ellenberger, Peter Flachenecker et al. · Multiple Sclerosis Journal · 2018 · 140 citations

Medicine, Neurology, Disability Management +14

Quality of life and life circumstances in German myasthenia gravis patients

Sabine Twork, Susanne Wiesmeth, Jörg Klewer et al. · Health and Quality of Life Outcomes · 2010 · 123 citations · Full text

Medicine, Internal Medicine, Neurology +13